Search clinical trials for: OBP-301
Total 5051 results
-
Aardvark Therapeutics, Inc.Children's Hospital Colorado; Stanford UniversityRecruiting
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Blue Blood Biotech Corp.Completed
-
Paean Biotechnology Inc.CompletedDermatomyositis | PolymyositisKorea, Republic of
-
MedRhythms, Inc.Active, not recruitingChronic StrokeUnited States
-
Auregen Biotherapeutics, SAEnrolling by invitation
-
Vergent Bioscience, Inc.National Cancer Institute (NCI)Completed
-
Stoke Therapeutics, IncEnrolling by invitationDravet SyndromeUnited States
-
Fervent PharmaceuticalsICON plcCompletedVasomotor Symptoms | MenopauseUnited States
-
SignalChem Lifesciences CorporationCompleted
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.Active, not recruitingMajor Depressive DisorderUnited States
-
Dr. Anupam SehgalTaysha Gene Therapies, Inc.; GlycoNetActive, not recruitingInfantile GM2 Gangliosidosis (Disorder)Canada
-
Innovo Therapeutics, Inc.Completed
-
Invenux, LLCState University of New York - Downstate Medical CenterActive, not recruitingSickle Cell Disease | Sickle-Beta Zero ThalassemiaUnited States
-
Ossium Health, Inc.Withdrawn
-
Pipeline Therapeutics, Inc.Completed
-
SignalChem Lifesciences CorporationSyneos HealthCompletedFood-drug InteractionCanada
-
Jazz PharmaceuticalsIqvia Pty LtdCompleted
-
Adicet Bio, IncEnrolling by invitationLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell LymphomaUnited States
-
Abeona Therapeutics, IncTerminatedMucopolysaccharidosis III-BUnited States, Germany, France
-
Lumen Bioscience, Inc.CompletedC. Diff. InfectionsAustralia
-
Forte Biosciences, Inc.Terminated
-
PfizerCompletedReduction in Hypertrophic Skin ScarringUnited States
-
Protagonist Therapeutics, Inc.CompletedChronic Anemia | β-thalassemia | Ineffective ErythropoiesisUnited States, Malaysia, Turkey, Thailand, United Kingdom, Italy, Lebanon, Tunisia, Greece
-
Stargazer Pharmaceuticals, Inc.Completed
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
AL-S PharmaUnknownAmyotrophic Lateral SclerosisCanada
-
Otonomy, Inc.Completed
-
United BioSource, LLCAveXis, Inc.Approved for marketing
-
ADC Therapeutics S.A.TerminatedAdvanced Solid TumorsUnited States
-
Benitec BioPharma LtdCompletedHead and Neck Squamous Cell CarcinomaAustralia, Russian Federation
-
FibroGenTerminatedFocal Segmental GlomerulosclerosisUnited States
-
Curis, Inc.Terminated
-
Minerva NeurosciencesCompletedHealthy SubjectsIreland
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Sarcoma Alliance for Research through CollaborationThreshold PharmaceuticalsNo longer availableSoft Tissue Sarcoma
-
Eleven BiotherapeuticsWithdrawn
-
Threshold PharmaceuticalsUnknown
-
Dolorgiet GmbH & Co. KGd.s.h. statistical services GmbH; CenTrial GmbHCompletedActinic Keratosis Olsen Grade I/IIGermany
-
HealthpointCompleted
-
Cerenis Therapeutics, SACompleted
-
HealthpointTerminatedSkin AbnormalitiesUnited States
-
Akros Pharma Inc.Completed
-
NorgineCompletedPostoperative IleusUnited Kingdom
-
M.D. Anderson Cancer CenterAlaunos TherapeuticsCompleted
-
Threshold PharmaceuticalsCompletedHypoxia | TumorsUnited States
-
C.B. Fleet Company, Inc.CompletedBowel Cleansing Prior to ColonoscopyUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedColorectal Neoplasms | Rectal Neoplasms | Colonic Neoplasms